CIC
PRAH

Carnegie Investment Counsel’s PRA Health Sciences, Inc. PRAH Stock Holding History

Carnegie Investment Counsel’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19,497
Closed -$2.99M – 487
2021
Q1 		$2.99M Sell
19,497
-82,101
-81% -$11.1M 0.13% 160
2020
Q4 		$12.7M Buy
101,598
+11,119
+12% +$1.24M 0.57% 56
2020
Q3 		$9.17M Buy
90,479
+5,947
+7% +$606K 0.47% 65
2020
Q2 		$8.22M Sell
84,532
-5,350
-6% -$498K 0.47% 62
2020
Q1 		$7.46M Sell
89,882
-6,734
-7% -$657K 0.52% 62
2019
Q4 		$10.7M Sell
96,616
-2,059
-2% -$212K 0.62% 45
2019
Q3 		$9.79M Buy
98,675
+6,173
+7% +$613K 0.62% 44
2019
Q2 		$9.17M Buy
92,502
+23,983
+35% +$2.29M 0.6% 48
2019
Q1 		$7.56M Buy
68,519
+5,394
+9% +$564K 0.52% 55
2018
Q4 		$5.8M Sell
63,125
-13,893
-18% -$1.41M 0.54% 55
2018
Q3 		$7.75M Buy
77,018
+17,052
+28% +$1.78M 0.64% 42
2018
Q2 		$6.08M Buy
59,966
+556
+0.9% +$47.9K 0.46% 66
2018
Q1 		$4.9M Buy
59,410
+22,509
+61% +$2M 0.41% 76
2017
Q4 		$3.26M Buy
36,901
+9,800
+36% +$815K 0.29% 104
2017
Q3 		$2.21M Buy
27,101
+8,211
+43% +$621K 0.26% 110
2017
Q2 		$1.41M Buy
18,890
+15,630
+479% +$1.08M 0.17% 144
2017
Q1 		$225K Buy
+3,260
New +$192K 0.03% 317

Other funds holding PRAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Carnegie Investment Counsel's PRAH Position: Q2 2021 in Review

Carnegie Investment Counsel sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 19,497 shares — an estimated $2.99M sold.

Carnegie Investment Counsel first reported a position in PRAH in Q1 2017 and held it in 17 quarters. The position peaked at $12.7M in Q4 2020. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Carnegie Investment Counsel reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Carnegie Investment Counsel sold 19,497 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $2.99M.
  • Carnegie Investment Counsel first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 17 quarters.
  • Carnegie Investment Counsel's PRA Health Sciences, Inc. position peaked at $12.7M in Q4 2020.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Carnegie Investment Counsel's 13F filing for Q2 2021, filed 16 Jul 2021.